The Conversation (0)
Chart
Detailed Quote
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in Boulder, Colorado.
Featured Articles and Interviews
May 11, 2026
5 Biggest Pharmaceutical ETFs for Investors in 2026
Dec 13, 2022
Top 5 NASDAQ Biotech Stocks (Updated December 2022)
Press Releases
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.

